Humatrope Articles

Biosimilars outlook brighter on CHMP EPO recommendations and US Senate moves

20 August 2007

Eli Lilly Japan's 2006 sales up 7% to $700M

2 April 2007

Polish biotech Bioton buys Biopartners

26 March 2007

Eli Lilly PAP approved, patients hit by Part D loophole

9 October 2006

Emisphere/Lilly trial oral hGH product

12 August 2002

US pharma's R&D cost claims "cannot be reconciled with its IRS filings,"

5 December 2001

Two new therapies for Crohn's studied

2 June 2000

Gen-eng drug market growth "to be driven by products not yet launched"

20 July 1999

Lilly's Humatrope For Turner Syndrome

23 December 1996

Mixed Earnings But Strong Sales For US Companies

12 February 1996

US 3rd Qrt Results: Strong Gains For Pfizer, Lilly

23 October 1995

Good Year for Eli Lilly Driven By Prozac

20 February 1995

Lilly And Genentech Settle Out Of Court

16 January 1995

BIOPHARMACEUTICALS MARKET GROWING FAST

13 June 1994

GENENTECH'S hGH APPROVED IN USA

21 March 1994

RESTRUCTURING CHARGES DEPRESS LILLY AND E KODAK

14 February 1994

US 3rd QTR RESULTS MIXED AS DRUG IND CUTS BACK

25 October 1993

ADVANCES BY US DRUG COMPANIES IN 2nd QTR

26 July 1993

GENENTECH TEMPERS PATENT POSITION

28 June 1993

Showing 1-19 of 19 articles

Go to beginningPrevious
  • 1
NextGo to end